SAN DIEGO and CALGARY, AB - Oncolytics Biotech Inc. (NASDAQ: NASDAQ:ONCY) (TSX: ONC), a biotechnology firm focused on immunotherapy for cancer, has received a notification from the Nasdaq regarding ...
2025 under a new ticker symbol, “HTB”. The Company’s common stock is expected to continue to trade on NASDAQ until the close of the market on Friday, February 21, 2025. “We are excited to ...
SAN JOSE, CA - Peraso Inc. (NASDAQ:PRSO), a semiconductor company trading below its InvestingPro Fair Value, disclosed in a recent SEC filing on February 14, 2025, the award of stock options to three ...
BioAtla, Inc., a biotechnology firm specializing in biological products, received notice from The Nasdaq Stock Market on Tuesday that it is at risk of being delisted. Currently trading at $0.45, the ...